Mounjaro®
Starting from £179.99/mo
Start journey Learn moreNausea and loose stools are the most commonly reported side effects of Mounjaro (tirzepatide), affecting a significant proportion of people, particularly in the first few weeks of treatment or after a dose increase. They are listed in the medicine's Summary of Product Characteristics and discussed in detail on the NHS tirzepatide medicines page. For most people, these symptoms are mild to moderate, settle within days to a couple of weeks, and do not mean treatment needs to stop. That said, a small number of people do experience sickness and diarrhoea on Mounjaro severely enough to need medical guidance, so knowing what to watch for matters.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Mounjaro works partly by slowing gastric emptying: food sits in the stomach longer, which reduces appetite but also means your gut is doing something noticeably different. The GI tract responds with nausea, occasional vomiting, loose stools, or all three. This is not an allergic reaction or a sign the medicine is failing, it is a direct, predictable result of how tirzepatide interacts with GIP and GLP-1 receptors in the gut lining.
The timing is telling. Symptoms usually appear within the first day or two after each injection, then gradually ease as the week goes on. If you have just moved to a higher dose, expect a similar pattern to restart briefly. Our full overview of Mounjaro side effects covers the broader picture, but sickness and diarrhoea are consistently the ones people ask about most in the early weeks.
A few things tend to make nausea worse: eating large meals, fatty or highly seasoned food, eating too quickly, or lying down shortly after eating. Smaller meals eaten slowly, and staying upright for at least an hour afterwards, often help considerably. Staying well hydrated matters too, especially if diarrhoea is present, because fluid loss adds to how unwell you feel. It is also worth being aware of the wider safety profile of this medicine, including what we know about Mounjaro and stroke risk, so you can make fully informed decisions throughout your treatment.
For most people, practical adjustments get them through the adjustment phase without needing to pause or abandon the medicine. Start with portions: cutting meal size by roughly a third, increasing protein and vegetables at the expense of high-fat foods, and eating slowly. Plain foods (rice, toast, boiled potato) tend to be better tolerated when your gut is unsettled.
Hydration is the single most important thing to protect during diarrhoea. Water is fine; oral rehydration sachets (available from any pharmacy) replace the salts lost with frequent loose stools. If keeping fluids down is difficult, sipping small amounts regularly beats drinking large volumes at once.
There is more detailed practical guidance on managing diarrhoea during Mounjaro treatment, and a separate resource on easing sickness on Mounjaro if nausea is your main concern. Do not adjust your dose timing or skip injections without speaking to your prescriber first, the titration schedule exists for a reason, and an unplanned break can reset your tolerance.
Most people find symptoms are at their worst in the first week after starting 2.5mg, then again briefly after each increase. By the time someone has been on their maintenance dose for a month, many report GI side effects have largely resolved. That pattern is worth knowing when you are in the middle of a difficult Tuesday.
Ordinary GI upset on Mounjaro is unpleasant but manageable. A different set of symptoms requires prompt attention. Seek medical help (from your prescriber, GP, or NHS 111) if you experience any of the following: vomiting or diarrhoea that is severe and has not eased after 48 hours; signs of dehydration such as very dark urine, dizziness on standing, or significantly reduced urination; or an inability to keep any fluids down at all.
The MHRA's January 2026 Drug Safety Update highlighted acute pancreatitis as an infrequent but serious known risk with GLP-1 medicines. The hallmark symptom is severe, persistent stomach pain that radiates to the back, sometimes accompanied by vomiting, this is distinct from ordinary nausea and needs urgent medical assessment, not a wait-and-see approach. You can read the MHRA's safety communications at the Yellow Card scheme, which also lets you report any suspected side effect directly.
If you are concerned about a symptom that is not covered here, the dedicated sickness and diarrhoea resource goes into further clinical detail, and our aftercare team is available seven days a week.
Sickness and diarrhoea that is improving slowly is usually safe to manage with the steps above. But some situations call for a prescriber's input rather than self-management. If symptoms are severe enough that you are losing significant weight beyond what you would expect, are affecting your ability to work or look after yourself, or have been going on for more than two to three weeks without real improvement, your prescriber can discuss options, whether that is a temporary dose delay, an extended time at the current dose before titrating, or an antiemetic in some cases.
At nume, our prescribers discuss side effects and suitability before treatment starts and are available through aftercare if problems arise afterwards. That is part of what a clinically reviewed prescription covers, rather than something billed separately. If you are still exploring whether Mounjaro is the right option for you, you can learn more about the medicine on our Mounjaro treatment page or explore the broader range of options on our weight-loss treatments overview. And if you have questions about whether you meet the clinical criteria, our prescribers work through that as part of the free consultation, check your eligibility here.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.